Find your next paid study

University of North Carolina, GreensboroNCT06921499

Actual pay is set by the research site.

Emotion RegulationRelationship ConflictSuicide Risk+4 more

Better Together: A Relationship Enrichment Program Targeting Transdiagnostic Interpersonal Emotion Regulation Among Military Couples

This study is testing a program called Get Better Together, a relationship education program designed to help military couples effectively navigate life stress…

Henry M. Jackson Foundation for the Advancement of Military MedicineNCT07096271

Actual pay is set by the research site.

Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+8 more

A Phase 1/2a Study of the Safety, Tolerability, and Preliminary Clinical Activity of 177LuBetaBart, a 177Lu-Labeled Anti-B7-H3 Monoclonal Antibody, in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

This is a Phase 1/2a dose escalation and expansion study to determine the safety, tolerability, and preliminary clinical activity of 177LuBetaBart, a lutetium-…

Chronic Obstructive Pulmonary Disease

~$150 – $4,200

Actual pay is set by the research site.

Phase 3

A Phase 2b/Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared…

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT07190222

Cervical CancerHpvHuman Papilloma Virus+1 more

Uptake of HPV Self-sampling in Underserved Minority Women Using a Community Health Worker Model: Comparison of Evalyn Brush and Copan Floqswab

Phase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibil…

Thomas Jefferson UniversityNCT07336134

Actual pay is set by the research site.

CardiovascularCardiovascular (CV) RiskCardiovascular Disease (CVD) Risk Factors+1 more

Improving the Cardiovascular Health of Home Health Aides

The goal of this early-stage study is to support the heart health of home health aides, a workforce that provides care for adults at home but whose own health …

Weill Medical College of Cornell UniversityNCT07067398

Actual pay is set by the research site.

Metastatic Soft Tissue SarcomaUnresectable Soft Tissue Sarcoma

A First-in-human, Phase 1/2, Multicenter, Open-label, Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of ADCE-D01, a Humanized Anti-human uPARAP Antibody Linked to a Topoisomerase I Inhibitor, in Patients With Metastatic and/or Unresectable Soft Tissue Sarcoma

The goal of this clinical trial is to learn about the safety, tolerability and efficacy of ADCE-D01.

~$150 – $4,500

Actual pay is set by the research site.

Adcendo ApSNCT06797999

Chronic Obstructive Pulmonary DiseaseObstructive Sleep ApneaOverweight and Obesity

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

The investigators will conduct a Type I hybrid effectiveness-implementation study to test an integrated telehealth intervention among 400 overweight and obese …

Seattle Institute for Biomedical and Clinical ResearchNCT06390345

Actual pay is set by the research site.

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at …

Neoplasm, ColorectalCognitive ImpairmentCognitive Dysfunction+5 more

Joseph McCollomNCT05014399

~$10 – $1,125

Actual pay is set by the research site.

Relapsed or Refractory Follicular Lymphoma

Phase 1 Study of huCART19-IL18-eDHFR Cells in Patients With Relapsed or Refractory Follicular Lymphoma

This is a phase 1, open-label study to evaluate the feasibility, safety and preliminary efficacy of huCART19-IL18-eDHFR cells administered in patients with rel…

University of PennsylvaniaNCT07343934

~$150 – $3,000

Actual pay is set by the research site.

Vulvar AdenocarcinomaPDAC - Pancreatic Ductal AdenocarcinomaGastric Adenocarcinoma+6 more

A Phase 1, Open Label, Dose-Escalation and Expansion Study to Evaluate Safety, Pharmacokinetics and Initial Therapeutic Activity of AVA6103, a Novel FAP-activated Exatecan Administered Intravenously in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

This is a first-in-human (FIH), Phase 1 open-label, multicenter dose escalation study investigating AVA6103 monotherapy administered intravenously in patients …

Locally Advanced Adrenal Cortical CarcinomaMetastatic Adrenal Cortical CarcinomaRecurrent Adrenal Cortical Carcinoma+3 more

~$150 – $4,200

Actual pay is set by the research site.

Avacta Life Sciences Ltd

Phase 2

A Phase II Study of Cabozantinib in Combination With Cemiplimab (Cabo-Cemiplimab) Versus Cabozantinib Alone in Adolescents and Adults With Advanced Adrenocortical Cancer

This phase II trial compares the effect of giving cabozantinib with or without cemiplimab in patients with adrenocortical cancer that has spread to nearby tiss…